Why CVS Health stock could appreciate 35% from here
On October 4, 2024, TD Cowen upgraded CVS Health (NYSE: CVS) to Buy from Hold, raising its price target to $85 from $59. This represents a potential upside of 35%,…
Input your search keywords and press Enter.